Bioaltus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 7.60 M
as on 16-11-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.50 Cr
as on 16-11-2024
- Satisfied Charges ₹ 8.22 Cr
as on 16-11-2024
About Bioaltus Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.60 M.
The company currently has active open charges totaling ₹7.50 Cr. The company has closed loans amounting to ₹8.22 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gopinath Nair and Ankit Varshney serve as directors at the Company.
- CIN/LLPIN
U74900MH2014PTC254786
- Company No.
254786
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bioaltus Pharmaceuticals Private Limited offer?
Bioaltus Pharmaceuticals Private Limited offers a wide range of products and services, including Printing & Binding Services, Printing Services, Anticoagulant and Antiplatelet Drugs, Enoxaparin Injection, API Intermediate, API (Active Pharmaceutical Ingredients), Pharmaceutical Pellets, Health Conditions, Mental Wellness.
Who are the key members and board of directors at Bioaltus Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopinath Nair  | Whole-Time Director | 18-Aug-2014 | Current |
| Ankit Varshney | Whole-Time Director | 21-Mar-2014 | Current |
Financial Performance of Bioaltus Pharmaceuticals.
Bioaltus Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bioaltus Pharmaceuticals?
In 2023, Bioaltus Pharmaceuticals had a promoter holding of 96.84% and a public holding of 3.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bioaltus Lifesciences Private LimitedActive 1 year 4 monthsGopinath Nair and Ankit Varshney are mutual person
- Finaltus Financial Solutions Private LimitedActive 5 years 6 months
Gopinath Nair and Ankit Varshney are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 31 Dec 2022 | ₹7.50 Cr | Open |
Others Creation Date: 13 Jan 2022 | ₹5.00 M | Satisfied |
Others Creation Date: 19 May 2020 | ₹4.00 Cr | Satisfied |
How Many Employees Work at Bioaltus Pharmaceuticals?
Bioaltus Pharmaceuticals has a workforce of 28 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioaltus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioaltus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
